Literature DB >> 11564763

Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types.

L Dumoutier1, C Leemans, D Lejeune, S V Kotenko, J C Renauld.   

Abstract

IL-10-related cytokines include IL-20 and IL-22, which induce, respectively, keratinocyte proliferation and acute phase production by hepatocytes, as well as IL-19, melanoma differentiation-associated gene 7, and AK155, three cytokines for which no activity nor receptor complex has been described thus far. Here, we show that mda-7 and IL-19 bind to the previously described IL-20R complex, composed by cytokine receptor family 2-8/IL-20Ralpha and DIRS1/IL-20Rbeta (type I IL-20R). In addition, mda-7 and IL-20, but not IL-19, bind to another receptor complex, composed by IL-22R and DIRS1/IL20Rbeta (type II IL-20R). In both cases, binding of the ligands results in STAT3 phosphorylation and activation of a minimal promoter including STAT-binding sites. Taken together, these results demonstrate that: 1) IL-20 induces STAT activation through IL-20R complexes of two types; 2) mda-7 and IL-20 redundantly signal through both complexes; and 3) IL-19 signals only through the type I IL-20R complex.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11564763     DOI: 10.4049/jimmunol.167.7.3545

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  114 in total

Review 1.  Structure and function of interleukin-22 and other members of the interleukin-10 family.

Authors:  Daniela Barretto Barbosa Trivella; José Ribamar Ferreira-Júnior; Laure Dumoutier; Jean-Christophe Renauld; Igor Polikarpov
Journal:  Cell Mol Life Sci       Date:  2010-05-08       Impact factor: 9.261

2.  Regulation of apoptosis by type III interferons.

Authors:  W Li; A Lewis-Antes; J Huang; M Balan; S V Kotenko
Journal:  Cell Prolif       Date:  2008-12       Impact factor: 6.831

3.  Structure of IL-22 bound to its high-affinity IL-22R1 chain.

Authors:  Brandi C Jones; Naomi J Logsdon; Mark R Walter
Journal:  Structure       Date:  2008-07-03       Impact factor: 5.006

4.  Interleukin-19 induces angiogenesis in the absence of hypoxia by direct and indirect immune mechanisms.

Authors:  Farah Kako; Khatuna Gabunia; Mitali Ray; Sheri E Kelemen; Ross N England; Bashar Kako; Rosario G Scalia; Michael V Autieri
Journal:  Am J Physiol Cell Physiol       Date:  2016-04-06       Impact factor: 4.249

5.  Interleukin-20 receptor expression in the trabecular meshwork and its implication in glaucoma.

Authors:  Kate E Keller; Yong-Feng Yang; Ying Ying Sun; Renee Sykes; Natalie Donna Gaudette; John R Samples; Ted S Acott; Mary K Wirtz
Journal:  J Ocul Pharmacol Ther       Date:  2014-01-23       Impact factor: 2.671

6.  Interleukin-20 promotes airway remodeling in asthma.

Authors:  Wenbin Gong; Xin Wang; Yuguo Zhang; Junqing Hao; Chunyan Xing; Qi Chu; Guicheng Wang; Jiping Zhao; Junfei Wang; Qian Dong; Tian Liu; Yuanyuan Zhang; Liang Dong
Journal:  Inflammation       Date:  2014-12       Impact factor: 4.092

Review 7.  Structure of interleukin-10/interleukin-10R1 complex: a paradigm for class 2 cytokine activation.

Authors:  Mark R Walter
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

Review 8.  Role of MDA-7/IL-24 a Multifunction Protein in Human Diseases.

Authors:  Mitchell E Menezes; Praveen Bhoopathi; Anjan K Pradhan; Luni Emdad; Swadesh K Das; Chunqing Guo; Xiang-Yang Wang; Devanand Sarkar; Paul B Fisher
Journal:  Adv Cancer Res       Date:  2018-03-02       Impact factor: 6.242

9.  Molecular modeling of the interleukin-19 receptor complex. Novel aspects of receptor recognition in the interleukin-10 cytokine family.

Authors:  Dorothee Preimel; Heinrich Sticht
Journal:  J Mol Model       Date:  2004-07-09       Impact factor: 1.810

10.  The p38 MAPK regulates IL-24 expression by stabilization of the 3' UTR of IL-24 mRNA.

Authors:  Kristian Otkjaer; Helmut Holtmann; Tue Wenzel Kragstrup; Søren Riis Paludan; Claus Johansen; Matthias Gaestel; Knud Kragballe; Lars Iversen
Journal:  PLoS One       Date:  2010-01-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.